Look for:

Our offer for

BRISTOL-MYERS SQUIBB CO.


ISIN:
US1101221083
WKN:
110122108

2024/05/29 22:00:02
Price
40.25 USD
Difference -0.59% (-0.24)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)75,539 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)40.25 USD (2,100)
Ask (Ask size)40.41 USD (100)
Open40.28 USD
High40.70 USD
Low39.935 USD
Close (prev. day)40.49 USD
VWAP40.316395 USD
Volume (pcs)16,492,496
Trading volume664,944,951.69
Number of trades110,991
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/05/29 22:00:02
Price
40.25 USD
Difference -0.59% (-0.24)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)75,539 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)40.25 USD (2,100)
Ask (Ask size)40.41 USD (100)
Open40.28 USD
High40.70 USD
Low39.935 USD
Close (prev. day)40.49 USD
VWAP40.316395 USD
Volume (pcs)16,492,496
Trading volume664,944,951.69
Number of trades110,991
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-16.13%-37.41%-30.90%
Perf (abs.)-7.16-22.26-16.65
Beta0.530.510.32
Volatility23.4022.2321.15
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)41.17 USD (15,563,304)
Ø price 30 days | Ø volume 30 days (pcs.)44.58 USD (14,605,865)
Ø price 100 days | Ø volume 100 days (pcs.)48.95 USD (15,487,862)
Ø price 250 days | Ø volume 250 days (pcs.)54.34 USD (13,369,847)
YTD High | date55.04 USD (2024/03/13)
YTD Low | date39.94 USD (2024/05/29)
52 Weeks High | date66.46 USD (2023/06/05)
52 Weeks Low | date39.94 USD (2024/05/29)

All listings for BRISTOL-MYERS SQUIBB CO.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/05/2917:3537.58 EUR0.1457
Vienna Stock Exchange2024/05/2917:3237.485 EUR0.002
Tradegate2024/05/3008:3737.57 EUR0.0815
Stuttgart2024/05/3008:0637.015 EUR0.001
SIX Swiss Exchange2019/06/2817:3544.39 CHF0.001
SIX Swiss Exchange2019/07/0305:5545.30 USD0.001
NYSE2024/05/2922:0040.25 USD664.94110,991
Munich2024/05/3008:1137.17 EUR0.001
London Stock Exchange European Trade Reporting2024/05/2917:3040.33 USD0.0010
Hanover2024/05/3008:2637.11 EUR0.001
Hamburg2024/05/3008:1737.09 EUR0.001
Frankfurt2024/05/2919:1537.49 EUR0.018
Euronext Milan MTF Trading After Hours2024/02/2818:5246.90 EUR0.001
Euronext Milan MTF Global Equity Market2024/05/2917:4437.385 EUR0.002
Duesseldorf2024/05/3008:1036.965 EUR0.001
Berlin2024/05/3008:1137.005 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=716&ID_TYPE_IMAGE_LOGO=2

Contact Details

BRISTOL MYERS SQUIBB CO.
- -
Route 206 & Province Line Road - 08543 Princeton
Telefon: +1-609-252-4621
Fax: +
E-mail: -

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Company Profile

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Members of Management Board

Deepak BhattMember of Board of Directors
Julia HallerMember of Board of Directors
Karen VousdenMember of Board of Directors
Manuel Hidalgo MedinaMember of Board of Directors
Derica RiceMember of Board of Directors
Paula PriceMember of Board of Directors
Peter ArduiniMember of Board of Directors
Phyllis YaleMember of Board of Directors
Theodore SamuelsMember of Board of Directors
Chris BoernerChairman of Managing Board
Adam LenkowskyMember of Executive Committee
Amanda PooleMember of Executive Committee
Cari GallmanMember of Executive Committee
David ElkinsMember of Executive Committee
Greg MeyersMember of Executive Committee
Karin ShanahanMember of Executive Committee
Kim JablonskiMember of Executive Committee
Lynelle B. HochMember of Executive Committee
Pamela FisherMember of Executive Committee
Peter S. Paine IIIMember of Executive Committee
Robert PlengeMember of Executive Committee
Samit HirawatMember of Executive Committee
Sandra LeungMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer